REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.69
+0.07 (0.81%)
At close: Apr 28, 2026, 4:00 PM EDT
8.70
+0.01 (0.12%)
After-hours: Apr 28, 2026, 7:56 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $448.55 million as of April 28, 2026. Its market cap has increased by 65.52% in one year.
Market Cap
448.55M
Enterprise Value
468.22M
1-Year Change
65.52%
Ranking
Category
Stock Price
$8.69
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $448.55M, a decrease of -40.14%. That is a compound annual growth rate of -4.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 444.90M | -38.97% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 462.01M |
| Climb Bio | 458.58M |
| Contineum Therapeutics | 456.25M |
| Candel Therapeutics | 451.20M |
| Ginkgo Bioworks Holdings | 450.52M |
| Larimar Therapeutics | 450.33M |
| Eupraxia Pharmaceuticals | 445.74M |
| Aura Biosciences | 444.26M |